Large scale causal modeling to identify adults at risk for combined and common variable immunodeficiencies

Giorgos Papanastasiou1, Marco Scutari2, Raffi Tachdjian3,4

  • 1Pfizer Inc., New York, NY, USA. georgios.papanastasiou@pfizer.com.

NPJ Digital Medicine
|June 14, 2025
PubMed
Abstract